Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rivat

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Annales De Dermatologie Et De Venereologie|June 1, 1977
[IgG levels in the sera of melanoma patients (author's transl)]M Daveau, J Pavie-Fischer, L Rivat, et al.
Journal of the National Cancer Institute|February 1, 1977
IgG4 subclass in malignant melanomaM Daveau, J Pavie-Fischer, L Rivat, et al.
Annales D'Immunologie|January 1, 1977
[IgG subclasses in malignant melanoma]M Daveau, J Pavie-Fischer, L Rivat, et al.
Journal of Immunogenetics|April 1, 1982
Association of the C2-deficiency gene (C2*QO) with the C4A*4, C4B*2 genesG Hauptmann, M M Tongio, J Goetz, et al.
Journal of Immunogenetics|June 1, 1983
HLA A*, B*-BF* and C4 A*, B* allele associations, with special reference to BF*S07, in the Tunisian populationA N Helal, G Lefranc, G Hauptmann, et al.
Molecular Psychiatry|November 2, 2016
Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depressionE Bouvier, F Brouillard, J Molet, et al.
Molecular Psychiatry|September 21, 2016
Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depressionE Bouvier, F Brouillard, J Molet, et al.
Nature Medicine|August 9, 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Nature Medicine|January 25, 2022
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Annales De Dermatologie Et De Venereologie|June 1, 1977
[IgG levels in the sera of melanoma patients (author's transl)]M Daveau, J Pavie-Fischer, L Rivat, et al.
Journal of the National Cancer Institute|February 1, 1977
IgG4 subclass in malignant melanomaM Daveau, J Pavie-Fischer, L Rivat, et al.
Annales D'Immunologie|January 1, 1977
[IgG subclasses in malignant melanoma]M Daveau, J Pavie-Fischer, L Rivat, et al.
Journal of Immunogenetics|April 1, 1982
Association of the C2-deficiency gene (C2*QO) with the C4A*4, C4B*2 genesG Hauptmann, M M Tongio, J Goetz, et al.
Journal of Immunogenetics|June 1, 1983
HLA A*, B*-BF* and C4 A*, B* allele associations, with special reference to BF*S07, in the Tunisian populationA N Helal, G Lefranc, G Hauptmann, et al.
Molecular Psychiatry|November 2, 2016
Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depressionE Bouvier, F Brouillard, J Molet, et al.
Molecular Psychiatry|September 21, 2016
Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depressionE Bouvier, F Brouillard, J Molet, et al.
Nature Medicine|August 9, 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Nature Medicine|January 25, 2022
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndromeA Magnani, M Semeraro, F Adam, et al.
Pageof 10